Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis-2 - APRICOT-2


The goal of the APRICOT-2 trial was to compare the 3 month angiographic rate of reocclusion in patients treated with aspirin alone to patients treated with a combination of coumarin and aspirin following successful fibrinolysis for ST-elevation myocardial infarction.